Bitcoin Fuels $32M Peptide Market Bypassing Banks

The peptide market has seen significant growth in recent times, with online sellers increasingly requiring Bitcoin as a form of payment. According to Chainalysis, gray-market peptide vendors received $32 million in cryptocurrency during the first quarter of 2026, a 700% increase from the same period last year.

Some suppliers use Bitcoin because banks and card networks often reject merchants selling unapproved compounds due to legal and regulatory risks. As a result, these vendors accept only cryptocurrency, making Bitcoin a payment tool for customers who previously avoided digital assets.

Zach, a 49-year-old marketing director, bought 20 vials of purported retatrutide from a Chinese seller for $240. The experimental weight-loss peptide is being developed by Eli Lilly & Co., and the vendor required Bitcoin. Zach opened an account with Coinbase Global Inc., bought Bitcoin, and transferred it to the seller.

Sara Graham, a senior intelligence analyst at Chainalysis, said the market is attracting first-time crypto buyers with no darknet market history. The products are promoted for sleep, focus, recovery, and anti-aging, but unlike approved peptide medicines such as Zepbound and Wegovy, many online alternatives have limited human safety or efficacy evidence.